Literature DB >> 29976521

Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin.

David M Whiley1, Amy Jennison2, Julie Pearson3, Monica M Lahra4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29976521     DOI： 10.1016/S1473-3099(18)30340-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  44 in total

1.  Emergence and Spread of Neisseria gonorrhoeae Strains with High-Level Resistance to Azithromycin in Taiwan from 2001 to 2018.

Authors:  Yen-Hung Liu; Ya-Hui Wang; Chun-Hsing Liao; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

2.  Recognition of the β-lactam carboxylate triggers acylation of Neisseria gonorrhoeae penicillin-binding protein 2.

Authors:  Avinash Singh; Joshua Tomberg; Robert A Nicholas; Christopher Davies
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

3.  Single-Arm Open-Label Clinical Trial of Two Grams of Aztreonam for the Treatment of Neisseria gonorrhoeae.

Authors:  Lindley A Barbee; Olusegun O Soge; Negusse Ocbamichael; Angela LeClair; Matthew R Golden
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

4.  High in vitro susceptibility to the first-in-class spiropyrimidinetrione zoliflodacin among consecutive clinical Neisseria gonorrhoeae isolates from Thailand (2018) and South Africa (2015-2017).

Authors:  Susanne Jacobsson; Ranmini Kularatne; Rossaphorn Kittiyaowamarn; Venessa Maseko; Porntip Paopang; Pongsathorn Sangprasert; Pachara Sirivongrangson; Laura Piddock; Teodora Wi; Emilie Alirol; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

Review 5.  Expanding U.S. Laboratory Capacity for Neisseria gonorrhoeae Antimicrobial Susceptibility Testing and Whole-Genome Sequencing through the CDC's Antibiotic Resistance Laboratory Network.

Authors:  Ellen N Kersh; Cau D Pham; John R Papp; Robert Myers; Richard Steece; Grace Kubin; Romesh Gautom; Evelyn E Nash; Samera Sharpe; Kim M Gernert; Matthew Schmerer; Brian H Raphael; Tara Henning; Anne M Gaynor; Olusegun Soge; Karen Schlanger; Robert D Kirkcaldy; Sancta B St Cyr; Elizabeth A Torrone; Kyle Bernstein; Hillard Weinstock
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

Review 6.  Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction.

Authors:  Arlene C Seña; Laura Bachmann; Christine Johnston; Teodora Wi; Kimberly Workowski; Edward W Hook; Jane S Hocking; George Drusano; Magnus Unemo
Journal:  Lancet Infect Dis       Date:  2020-06-19       Impact factor: 25.071

7.  Mutations in penicillin-binding protein 2 from cephalosporin-resistant Neisseria gonorrhoeae hinder ceftriaxone acylation by restricting protein dynamics.

Authors:  Avinash Singh; Jonathan M Turner; Joshua Tomberg; Alena Fedarovich; Magnus Unemo; Robert A Nicholas; Christopher Davies
Journal:  J Biol Chem       Date:  2020-04-06       Impact factor: 5.157

8.  Genomic Analysis Reveals Antibiotic-Susceptible Clones and Emerging Resistance in Neisseria gonorrhoeae in Saskatchewan, Canada.

Authors:  Nidhi R Parmar; Reema Singh; Irene Martin; Sumudu R Perera; Walter Demczuk; Anthony Kusalik; Jessica Minion; Jo-Anne R Dillon
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

9.  Quantitative Proteomics of the 2016 WHO Neisseria gonorrhoeae Reference Strains Surveys Vaccine Candidates and Antimicrobial Resistance Determinants.

Authors:  Fadi E El-Rami; Ryszard A Zielke; Teodora Wi; Aleksandra E Sikora; Magnus Unemo
Journal:  Mol Cell Proteomics       Date:  2018-10-23       Impact factor: 5.911

Review 10.  The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae.

Authors:  Daniel H F Rubin; Jonathan D C Ross; Yonatan H Grad
Journal:  Transl Res       Date:  2020-02-29       Impact factor: 7.012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.